Levels of syndecan-1 and hyaluronan in early- and late-onset preeclampsia

Pregnancy Hypertens. 2019 Oct:18:108-111. doi: 10.1016/j.preghy.2019.08.165. Epub 2019 Oct 3.

Abstract

Objective: The study aimed to assess serum levels of syndecan-1 (SDC-1) and hyaluronan (HA) in patients with early- and late-onset preeclampsia (PE).

Study design: Blood samples were collected in the third trimester of pregnancy from 20 women with early-onset PE, 20 with late-onset PE, and 20 with normal pregnancy for the assessment of serum levels of SDC-1 and HA as markers of endothelial injury. PE was categorized as early-onset when diagnosed at <34 weeks of gestation and as late-onset when diagnosed at ≥34 weeks of gestation.

Main outcome measures: The degree of endothelial injury in different forms of preeclampsia expressed by serum concentrations of SDC-1 and HA.

Results: Concentration of HA was significantly higher and the level of SDC-1 was significantly lower in patients with PE than in the control group. However, the concentrations of both HA and SDC-1 did not differ significantly between the two groups of PE.

Conclusions: Degree of endothelium injury is comparable in patients with early- and late-onset PE.

Keywords: Endothelial injury; Glycocalyx; Placental insufficiency; Preeclampsia.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Case-Control Studies
  • Female
  • Humans
  • Hyaluronic Acid / blood*
  • Pre-Eclampsia / blood
  • Pre-Eclampsia / diagnosis*
  • Pregnancy
  • Pregnancy Trimester, Second
  • Pregnancy Trimester, Third
  • Prenatal Diagnosis*
  • Syndecan-1 / blood*
  • Young Adult

Substances

  • Biomarkers
  • SDC1 protein, human
  • Syndecan-1
  • Hyaluronic Acid